InsiderTrades

Form 4 for ELAN Elanco Animal Health Inc

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001415889-23-004281 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-03 2023-03-01 ELAN de Brabander Ellen SEE REMARKS F - Tax $11.26 -2,368 46.5K -5% -$26.7K
D 2023-03-03 2023-03-01 ELAN de Brabander Ellen SEE REMARKS A - Grant $0.00 +45.3K 91.8K +98% $0
D 2023-03-03 2023-03-01 ELAN de Brabander Ellen SEE REMARKS A - Grant $0.00 +103.5K 103.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 F D 2,368 $11.26 46,468 D — — (F1) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
2 Common Common Stock 2023-03-01 A A 45,338 $0.00 91,806 D — — (F2) Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.
3 Derivative Employee Stock Option (right to buy) 2023-03-01 A A 103,550 $0.00 103,550 D $11.26 · — to 2033-03-01 103,550 Common Stock (F3) Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.